To address (one hesitates to say “celebrate”) American Diabetes month, here is the latest addition to Pfizer’s Value of Medicines series -- The Value of Medicine for Type 2 Diabetes.
The development of medicines is complicated -- explaining their value should not be. Pfizer's straightforward efforts put the facts in perspective -- and in plain English. Their Value of Medicines series provides highly valuable tools for healthcare policy professionals, practitioners, and patients. Additional materials can be found here.
Knowledge is Power.
